Infectious diseases and vaccines Archives - Page 3 of 11

Human Papillomavirus Vaccine impact and effectiveness in six high-risk populations: a systematic literature review

Authors: E Goodman, M Reuschenbach, A Kaminski, S Ronnebaum Published: Vaccines, 2022 View publication Abstract Specific adult populations known to be at high risk for human papillomavirus (HPV)-related disease, such as men...

48-Week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-Infected patients: A systematic review and network meta-analysis

Authors: D A Patel, S J Snedecor, W Yu Tang, L Sudharshan, J W Lim, R Cuffe, S Pulgar, K A Gilchrist, R Refoios Camejo, J Stephens, G Nichols Published: PLoS ONE,...

Risk factors in people with mold infections that have spread to different parts of the body: a plain language summary

Authors: A H Sung, S Martin, B Phan, M Benigno, J Stephens, J A Aram Published: Future Microbiology, 2022 View publication What is this summary about?: This is a summary of a...

A need for implementation science to optimise the use of evidence-based interventions in HIV care: A systematic literature review

Authors: J Cox, C Gutner, N Kronfli, A Lawson, M Robbins, L Nientker, A Ostawal, T Barber, D Croce, D Hardy, H Jessen, C Katlama, J Mallolas, G Rizzardini, K Alcorn, M...

Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in participants with virologically suppressed HIV-1-infection

Authors: V Chounta, S J Snedecor, S Wu, N Van de Velde Published: BMC infectious diseases, 2022 View publication Background Efficacy and safety of long-acting cabotegravir (CAB) + rilpivirine (RPV) every 8...

An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant staphylococcus aureus nosocomial pneumonia in Germany

Authors: D A Patel, A Michel, J Stephens, B Weber, C Petrik, C Charbonneau Published: Infection and Drug Resistance, 2014 View publication Background Across Europe, methicillin-resistant Staphylococcus aureus (MRSA) is considered to...

Antibacterial treatment of Meticillin-Resistant Staphylococcus Aureus complicated skin and soft tissue infections: a cost and budget impact analysis in Greek hospitals

Authors: K Athanasakis, I Petrakis, M Ollandezos, C Tsoulas, D A Patel, E Karampli, J Kyriopoulos Published: Infectious Diseases and Therapy, 2014 View publication Introduction Meticillin-resistant staphylococcus aureus (MRSA) is an important...

Cost-effectiveness of the 15-valent pneumococcal conjugate vaccine for high-risk adults in Switzerland

Authors: A Deb, P Guggisberg, T Mutschler, K Owusu-Edusei, G Bencina, K D Johnson, T Ignacio, D A R Mathijssen, V Qendri Published: Expert Review of Vaccines, 2022 View publication Background Vaccination...

Cost-effectiveness of linezolid versus vancomycin among patients with methicillin-resistant staphylococcus aureus confirmed nosocomial pneumonia in China

Authors: E De Cock, W A Krueger, S Sorensen, T Baker, J Hardewig, S Duttagupta, E Müller, A Piecyk, E Reisinger, A Resch Published: Value in Health Regional Issues, 2014 View publication...

News